Detection of unknown atrial fibrillation by prolonged ECG monitoring in an all-comer patient cohort and association with clinical and Holter variables. by Jawad-Ul-Qamar, Muhammad et al.
 
 
University of Birmingham
Detection of unknown atrial fibrillation by prolonged
ECG monitoring in an all-comer patient cohort and
association with clinical and Holter variables.
Jawad-Ul-Qamar, Muhammad; Chua, Winnie Wei Ling; Purmah, Yanish; Nawaz,
Muhammad; Varma, Chetan; Davis,  Russell; Maher,  Abdul; Fabritz, Larissa; Kirchhof,
Paulus
DOI:
10.1136/openhrt-2019-001151
License:
Creative Commons: Attribution (CC BY)
Document Version
Publisher's PDF, also known as Version of record
Citation for published version (Harvard):
Jawad-Ul-Qamar, M, Chua, WWL, Purmah, Y, Nawaz, M, Varma, C, Davis, R, Maher, A, Fabritz, L & Kirchhof, P
2020, 'Detection of unknown atrial fibrillation by prolonged ECG monitoring in an all-comer patient cohort and
association with clinical and Holter variables.', Open Heart, vol. 7, no. 1, e001151.
https://doi.org/10.1136/openhrt-2019-001151
Link to publication on Research at Birmingham portal
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 14. Jun. 2020
Open access 
  1Jawad- Ul- Qamar M, et al. Open Heart 2020;7:e001151. doi:10.1136/openhrt-2019-001151
To cite: Jawad- Ul- Qamar M, 
Chua W, Purmah Y, et al. 
Detection of unknown atrial 
fibrillation by prolonged ECG 
monitoring in an all- comer 
patient cohort and association 
with clinical and Holter 
variables. Open Heart 
2020;7:e001151. doi:10.1136/
openhrt-2019-001151
The work for this paper was 
performed at the Department 
of Cardiology, Sandwell and 
West Birmingham Hospitals 
NHS Trust, UK and the Institute 
of Cardiovascular Sciences, 
University of Birmingham, 
Birmingham, UK.
Received 8 August 2019
Accepted 12 February 2020
1Institute of Cardiovascular 
Sciences, University of 
Birmingham, Birmingham, UK
2Department of Cardiology, 
Sandwell and West Birmingham 
Hospitals NHS Trust, West 
Bromwich, UK
3University Heart and Vascular 
Center UKE Hamburg, Hamburg, 
Germany
Correspondence to
Professor Paulus Kirchhof;  p. 
kirchhof@ bham. ac. uk
Detection of unknown atrial fibrillation 
by prolonged ECG monitoring in an all- 
comer patient cohort and association 
with clinical and Holter variables
Muhammad Jawad- Ul- Qamar,1,2 Winnie Chua,1 Yanish Purmah,1,2 
Mohammad Nawaz,2 Chetan Varma,2 Russell Davis,2 Abdul Maher,2 
Larissa Fabritz,1,2 Paulus Kirchhof  1,2,3
Arrhythmias and sudden death
© Author(s) (or their 
employer(s)) 2020. Re- use 
permitted under CC BY. 
Published by BMJ.
Key questions
What is already known about this subject?
 ► Systematic ECG monitoring is recommended for 
detection of atrial fibrillation (AF) in patients with 
ischaemic stroke.
What does this study add?
 ► Detection of AF through in an all- comer patient pop-
ulation through systematic ECG monitoring is not 
previously reported.
How might this impact on clinical practice?
 ► Judicious use of Holter ECG monitoring for new 
AF detection especially in the presence of clini-
cal factors increasing the chances of AF detection 
could have significant diagnostic and therapeutic 
implications.
AbstrAct
Objectives Prolonged ECG monitoring is clinically useful 
to detect unknown atrial fibrillation (AF) in stroke survivors. 
The diagnostic yield of prolonged ECG monitoring in other 
patient populations is less well characterised. We therefore 
studied the diagnostic yield of prolonged Holter ECG 
monitoring for AF in an unselected patient cohort referred 
from primary care or seen in a teaching hospital.
Methods We analysed consecutive 7- day ECG recordings 
in unselected patients referred from different medical 
specialities and assessed AF detection rates by indication, 
age and comorbidities.
Results Seven- day Holter ECGs (median monitoring 
127.5 hours, IQR 116 to 152) were recorded in 476 
patients (mean age 54.6 (SD 17.0) years, 55.9% female) 
without previously known AF, requested to evaluate 
palpitations (n=241), syncope (n=99), stroke or transient 
ischaemic attack (n=75), dizziness (n=29) or episodic 
chest pain (n=32). AF was newly detected in 42/476 
(8.8%) patients. Oral anticoagulation was initiated in 40/42 
(95.2%) patients with newly detected AF. Multivariate 
logistic regression, adjusted for age, sex and monitoring 
duration found four clinical parameters to be associated 
with newly detected AF: hypertension OR=2.54, (1.08 to 
8.61) (adjusted OR (95% CI)), p=0.034; previous stroke or 
TIA OR=4.14 (1.81 to 13.01), p=0.001; left- sided valvular 
heart disease OR=5.07 (2.48 to 18.70), p<0.001 and 
palpitations OR=2.86, (1.33 to 10.44), p=0.015.
Conclusions Open multispeciality access to prolonged 
ECG monitoring, for example, as part of integrated, 
cross- sector AF care, can accelerate diagnosis of AF and 
increase adequate use of oral anticoagulation, especially 
in older and symptomatic patients with comorbidities.
IntROduCtIOn
Atrial fibrillation (AF), a common cause 
of stroke and cardiovascular death, often 
remains undetected until a severe complica-
tion occurs, such as an ischaemic stroke.1 2 
Timely diagnosis of AF is a major clinical need 
with immediate therapeutic consequences in 
patients at high stroke risk who would benefit 
from oral anticoagulation.3 4 Systematic ECG 
monitoring improves detection of undiag-
nosed paroxysmal AF in survivors of a stroke 
or transient ischaemic attack (TIA), detecting 
AF in around 4% of unselected stroke survi-
vors using 3- day Holter monitoring5 6 and in up 
to 25% of selected patients with cryptogenic 
stroke using implantable monitors.3 7 Recent 
guidelines recommend at least 72 hours of 
ECG monitoring in stroke survivors to detect 
silent AF.1 8 The diagnostic yield of prolonged 
ECG monitoring in other groups of patients 
at risk of AF has not been studied systemat-
ically. We therefore quantified AF detection 
rates of 7- day Holter ECG monitoring in an 
unselected cohort of consecutive patients 
referred for such monitoring, and identified 
factors that are associated with detection of 
unknown AF by multivariate regression.
MetHOds
Patients and procedures
We analysed 584 consecutive 7- day Holter 
ECG recordings performed in adult patients 
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Figure 1 Overview of the patient population. AF, atrial 
fibrillation; TIA, transient ischaemic attack.
(>18 years) in Sandwell and West Birmingham Hospi-
tals (SWBH) NHS Trust from 1st April 2014 to 30th April 
2016. Open access 7- day Holter monitoring is available to 
hospital physicians and general practitioners in partici-
pating practices in our region for various indications. All 
recordings made through Spacelabs Healthcare modular 
digital Holter recorder, with Lifecard CF, were initially 
analysed and reported by trained cardiac physiologists 
using Pathfinder 1.71 running on Sentinel server V.17.1.1 
(Spacelabs, UK). All analyses were subsequently reviewed 
by two cardiology physicians (JQ, YP). We did not find any 
discrepancy between the initial analysis and its review for 
AF detection and any Holter ECG parameter of interest. 
We excluded 108 patients with known AF, those <18 years 
of age and recordings with <110 hours analysable moni-
toring duration. The remaining 476 recordings consti-
tuted our primary analysis data set (figure 1). Clinical 
information was verified by three researchers (JQ, YP, 
MN) from hospital records. This analysis was approved by 
the clinical effectiveness department at SWBH NHS Trust 
as part of our ongoing quality improvement programme 
(QIP SG323).
definitions
The study outcome, AF, was defined as chaotic atrial 
arrhythmia with loss of p wave activity and irregular 
RR interval lasting for at least 30 s. We defined atrial or 
supraventricular ectopic as narrow QRS complex similar to 
sinus beat with different or absent p wave and <80% of 
prevailing RR interval. Supraventricular ectopic (SVE) runs 
were defined as regular or irregular runs of three or more 
consecutive atrial ectopics lasting for less than 30 s. Sinus 
pause was defined as increase in RR interval due to delay 
in p wave activity resulting in a pause >2 s. We categorised 
significant atrial ectopy as ≥50 atrial ectopics/day and 
significant sinus pauses as ≥10 sinus pauses/day based on 
cut- offs calculated through receiver operating character-
istic (ROC) curve. All comorbidities were taken as previ-
ously documented through records from primary care or 
specialist clinics. Valvular disease was taken as moderate- 
to- severe left (mitral or aortic) valvular disease, stenosis 
or regurgitation confirmed on prior echocardiography.
statistical analysis
Normality was assessed by inspecting the frequency 
distribution curves. For normally distributed variables 
we reported mean and SD, for other parameters median 
and IQR. Categorical variables were compared using χ2 
tests and continuous variables using independent t- test 
or Mann- Whitney U test as appropriate. The p values of 
<0.05 were considered statistically significant. The cut- 
offs for continuous variables were calculated through 
the Youden's index (maximum sensitivity and minimum 
1- specificity) obtained from the receiver operating char-
acteristics (ROC) curve. The univariate relationship to the 
outcome was quantified using logistic regression. A multi-
variate logistic regression model through enter method 
was fitted using a combination of various clinical varia-
bles which includes hypertension, left- sided moderate/
severe valvular disease, previous cerebrovascular accident 
and palpitations which were chosen due to their clinical 
relevance. The derived model was adjusted for sex, age 
and duration of recording. The model was internally 
validated using bootstrapping to produce an optimism- 
adjusted model. We assessed the bootstrapped model’s 
performance by quantifying the C- statistic (equivalent 
to area under the ROC curve). All the statistical analyses 
were performed using SPSS V.24 (IBM).
Results
Clinical characteristics of the patient population and AF 
detection
Mean age of the study population was 56 years, 56% were 
female, and 40% were older than 60 years (table 1). AF 
was diagnosed in 42/476 patients (8.8%) of which three 
had new AF throughout the recording and the remaining 
had paroxysmal AF. Median number of AF episodes was 4 
(IQR 1.75 to 5.25), total duration of longest AF episode 
was 28 min (IQR 7.9 to 180.4) and median duration of 
longest episode was 731 min (IQR 3.9 to 115.1), respec-
tively. After detection of AF, 40/42 (95.2%) patients were 
started on oral anticoagulation.
Patients with AF detected were older (mean 69.8 
years, SD 69.8) with no significant difference in sex and 
31/42 (73.8%) patients with AF were age 60 years or 
more (figure 2). The AF group had more comorbidities 
such as hypertension, coronary artery disease, history of 
stroke or transient ischaemic attack, moderate- to- severe 
left- sided valvular disease and palpitations. There was no 
difference seen for diabetes and hypercholesterolaemia. 
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Table 1 Baseline characteristics, comorbidities and Holter parameters
Variable Total (n=476) AF detected (n=42) AF not detected (n=434) p value
Clinical parameters
  Age, years, mean (SD) 56.4 (17.0) 69.8 (12.2) 53.1 (16.7) <0.001
  Female, n (%) 266 (56) 22 (52) 244 (56) 0.632
  Hypertension, n (%) 173 (36.3) 32 (76.1) 141 (32.4) <0.001
  Diabetes, n (%) 78 (16.3) 11 (26.2) 67 (18) 0.072
  Coronary artery disease, n (%) 102 (21.4) 17 (40.4) 85 (19.5) 0.002
  Hypercholesterolaemia, n (%) 177 (37.1) 17 (40.4) 160 (36.8) 0.644
  History of stroke or transient ischaemic attack, n (%) 111 (23.3) 23 (54.7) 88 (20.2) <0.001
  Valvular disease, n (%) 72 (15.1) 18 (42.8) 54 (12.4) <0.001
  Palpitations, n (%) 241 (50.63) 32 (76.19) 209 (48.15) 0.001
Holter parameters
  Recording, hours, median (IQR) 127.5 (116 to 152) 153.4 (133.7 to 166.0) 124.0 (115.0 to 127.5) 0.001
  Mean heart rate, bpm, mean (SD) 79.9 (13.3) 104.7 (13.0) 77.5 (11.2) 0.001
  Max heart rate, bpm, mean (SD) 139.1 (18.2) 144.9 (12.4) 138.5 (18.6) 0.004
  Min heart rate, bpm, mean (SD) 49.2 (8.3) 50.4 (10.5) 49.0 (8.1) 0.417
  ≥10 sinus pauses/day (%) 77 (16.1) 26 (61.9) 51 (11.7) <0.001
  ≥50 atrial ectopics/day (%) 156 (32.7) 36 (85.7) 120 (27.6) <0.001
  ≥500 ventricular ectopics/recording (%) 443 (93) 42 (100) 401 (92.3) 0.064
  Supraventricular ectopic (SVE) runs, (%) 70 (14.7) 26 (61.9) 44 (10.1) <0.001
  Longest atrial run, mean (SD) 8.7 (4.0) 10.9 (2.8) 8.1 (4.0) <0.001
Data presented as number, n(percentage,%) for categorical variables, mean (SD) for parametric continuous variables, and median (IQR) for non- 
parametric continuous variables. p value is significant if < 0.05.
AF, atrial fibrillation; bpm, beats per minute; SD, Standard Deviation.
Figure 2 Number of patients with and without newly 
detected AF split by age deciles. Percentage of patients with 
newly detected AF is given above the bars for each decile. 
AF, atrial fibrillation.
Figure 3 Number of patients with and without newly 
detected AF by underlying conditions to justify the 7- day 
Holter monitor. AF, atrial fibrillation; CVA, cerebrovascular 
accident.
The recording duration in AF group was longer, median 
(IQR), 153.4 hours (133.7 to 166.0) versus non- AF group 
124.0 hours (115.0 to 127.5). Moreover there were more 
sinus pauses, atrial ectopics and SVE runs. If present, SVE 
runs were longer in the AF group. AF was more often 
found in stroke survivors (7/75, 9.3%) and in patients 
with palpitations (32/241, 13.3%) than in patients with 
dizziness (2/29, 6.8%), syncope (2/99, 2%) or chest pain 
(1/32, 3.1%) (figure 3). The source of referral for the test 
did not affect AF detection (cardiology 8.7% (19/218), 
general medicine 9% (19/222) and primary care 8.6% 
(4/46)).
Other relevant findings
Other medically relevant findings were second degree 
atrioventricular (AV) block (10/474, 2.1%), third degree 
AV block (2/474, 0.4%) and non- sustained ventricular 
tachycardia (12/474, 2.5%). These were all detected in 
patients who underwent monitoring for dizziness. Arte-
fact burden in the final cohort was 3.3% (SD 3.5)
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Table 2 Factors associated with unknown AF
Variables OR
95% Confidence 
Intervals (CI)
p value
Lower 
limit
Upper 
limit
Univariate logistic regression analysis
  Age (per year increase) 1.08 1.06 1.11 <0.001
  Hypertension 6.65 3.17 13.90 <0.001
  Diabetes 1.94 0.93 4.07 0.077
  Coronary artery disease 2.79 1.44 5.40 0.002
  Hypercholesterolaemia 1.16 0.61 2.22 0.644
  Valvular disease 5.27 2.68 10.35 <0.001
  Previous CVA/TIA 4.76 2.48 9.12 <0.001
  Palpitations 3.44 1.65 7.18 0.001
  Recording duration (per 
hour increase)
1.05 1.03 1.07 <0.001
  ≥10 sinus pauses/day 12.2 6.13 24.27 <0.001
  ≥50 AE/day 15.70 6.45 38.21 <0.001
  Presence of SVE runs 14.40 7.17 28.90 <0.001
Variables (bootstrapped)
Multivariate logistic regression analysis
  Hypertension 2.54 1.08 8.61 0.034
  Previous CVA 4.14 1.81 13.01 0.001
  Valvular disease 5.07 2.48 18.70 <0.001
  Palpitations 2.86 1.33 10.44 0.015
AE, atrial ectopic; AF, atrial fibrillation; CVA, cerebrovascular 
accident; SAE, significant atrial ectopy; SVE, supraventricular 
ectopic; TIA, transient ischaemic attack.
Figure 4 Individual predictors of newly detected AF by 
7- day Holter, shown as hazard ratio and 95% confidence 
interval. CVA,cerebrovascular accident.
Figure 5 Receiver operating characteristic (ROC) curves for 
the different AF prediction models. See text for details.CVA, 
cerebrovascular accident; TIA, transient ischaemic attack.
Clinical parameters associated with AF
Univariately, AF was more likely to be detected in patients 
who are older (OR 10.85, 95% CI 10.56 to 11.15 for each 
10 year increase in age), and in those presenting with 
palpitations (OR 3.44, 95% CI 1.65 to 7.18, p=0.001), have 
hypertension (OR 6.65, 95% CI 3.17 to 13.90, p<0.001), 
coronary artery disease (OR 2.79, 95% CI 1.44 to 5.40, 
p=0.003), history of ischaemic strokes or TIA (OR 4.76, 
95% CI 2.48 to 9.12, p<0.001), or moderate- to- severe 
left- sided valve disease (OR 5.27, 95% CI 2.68 to 10.35, 
p<0.001).
Holter parameters associated with AF
AF detection was also univariately associated with longer 
ECG monitoring (OR 1.05, 95% CI 1.03 to 1.07 for each 
additional hour of monitoring), sinus pauses (OR 12.2, 
95% CI 6.13 to 24.27, p<0.001), significant atrial ectopics 
(OR 15.70, 95% CI 6.45 to 38.21, p<0.001) and presence 
of SVE runs (OR 14.4, 95% CI 7.17 to 28.90, p<0.001, 
table 2).
Multivariate regression, performed through enter 
method identified four variables to be significantly asso-
ciated with undetected AF: Previous stroke or transient 
ischaemic attack bootstrapped OR=4.14 (95% CI 1.81 to 
13.01), p=0.001; left- sided moderate- to- severe valvular 
disease OR=5.07 (95% CI 2.48 to 18.70), p<0.001; palpi-
tations OR=2.86, (95% CI 1.33 to 10.44), p=0.015 and 
hypertension OR=2.54, (95% CI 1.08 to 8.61) p=0.034; 
table 2, figure 4. The model was adjusted for age, sex and 
duration of recording.
The area under the curve (C statistic) for our multi-
variate model was 0.91 (95% CI 0.87 to 0.95) with 
individual C- statistics for each variable mentioned in 
figure 5, table 3.
dIsCussIOn
We found that 7- day ECG monitoring detected unknown 
AF in 9% of an unselected cohort presenting with various 
symptoms. Almost all patients were initiated on oral anti-
coagulation following AF detection. The AF detection 
rates of 9.3% in stroke survivors is comparable to AF rates 
in IDEAS (4.3%, 72 hours monitoring,5 FIND- AF (12.5%, 
10 days monitoring)9 and FIND- AFrandomised (14%).
6 The 
data supports the wider use of systematic ECG monitoring 
to allow early initiation of therapy for AF, particularly 
stroke prevention, for example, as part of an integrated 
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Table 3 Area under the curve values and CIs
Variable(s) Area
95% Confidence 
Intervals (CI)
p value
Lower 
bound
Upper 
bound
Combined model 0.912 0.870 0.954 <0.001
Hypertension 0.719 0.639 0.798 <0.001
Previous CVA 0.672 0.580 0.765 <0.001
Valvular disease 0.652 0.555 0.749 <0.001
Palpitations 0.640 0.558 0.723 0.003
CVA, cerebrovascular accident.
approach to AF care. External validation of our findings 
is desirable.
Factors associated with newly detected AF
Patients with AF were older (table 1, figures 2 and 4) 
than those without AF, similar to other reports10 11 and 
consistent with the known finding that older age is 
associated with prevalent AF.12 13 We found that each 
decade increase in age increased the odds of detecting 
AF by 10.8. In addition, previous history of stroke and 
left- sided valvular heart disease was associated with silent 
AF in univariate analysis which is comparable to prior 
reports.14 15 In our study palpitations were the symptom 
that was most frequently associated with underlying AF 
(figure 4). Our analysis supports some prior reports asso-
ciating palpitations with AF16 while others found a more 
ephemeral nature of presenting symptoms.17 As expected, 
longer monitoring duration increased AF detection.18 In 
addition, excessive supraventricular ectopic activity was 
associated with unknown AF (table 2, figure 4), compa-
rable to prior analyses.19–21 Sinus node disease, identified 
by sinus pauses,22 has been linked to underlying AF.23 24 
Although, sinus pauses were not part of our multivariate 
model, but there is evidence to suggest that it could be 
associated with unknown AF, confirming findings from 
one prior study.25 We suggest further ECG monitoring, 
beyond 7 days, to look for AF in clinically high risk 
patients as identified by our multivariate model, espe-
cially, if they have evidence of significant atrial ectopy or 
sinus pauses on prior monitoring.
Open access eCG monitoring - an alternative approach to 
increase detection of unknown AF?
Current guidelines recommend pulse palpation followed 
by an ECG in patients with an irregular pulse in popu-
lations >65 years to detect AF.1 8 Pulse palpation can be 
replaced by a blood pressure machine.26 27 Systematic 
prolonged ECG monitoring is recommended in stroke 
survivors. In addition, community- based ECG screening 
programmes using patient- operated devices are able to 
identify patients with silent AF, especially when elderly 
populations are screened, for example, those aged 75 
years or more.28–30 Such population- based screening 
programmes require a specific infrastructure that is 
currently confined to a research environment or not 
available at all. Our study suggests that open access to 
prolonged ECG monitoring has a high diagnostic yield 
in patients with various symptoms, opening up an alter-
native approach to increase the detection of unknown 
AF. Open access to ECG monitoring has the advantage 
of using existing health infrastructure, but is limited to 
populations with symptoms.
limitations
Our findings will need validation in other, external 
patient cohorts. Although the number of patients in our 
study was reasonable for a busy teaching hospital however 
more patients are required for further studies especially 
to assess Holter ECG variables with incident AF. The 
number of patients also had an effect on the relatively 
wide CIs for the calculated ORs. AF group had longer 
duration of monitoring that could introduce bias. To 
rectify this we adjusted our multivariate variable for dura-
tion of recording. Moreover, older patient usually have 
higher incidence of comorbidities which may be one 
reason why the multivariate model strongly predicted AF.
COnClusIOn
Seven- day Holter ECG monitoring detects unknown 
AF in around 9% of patients with various symptoms in 
an open access, ‘all- comer’ setting, suggesting that this 
is a useful diagnostic approach to enhance detection 
of unknown AF. Risk factor analysis for paroxysmal AF 
and systematic evaluations of treatment and outcomes 
after AF screening are needed to define populations 
for screening silent AF. Comparable AF detection rates 
between cardiology and primary care also supports provi-
sion of ECG monitoring using open- access services across 
various healthcare sectors.
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